	Capital Ordinaire		Date
Acadia Pharmaceuticals	USD 168.71M	104K	2025-09
Adma Biologics	USD 236.62M	242K	2024-12
ALKERMES	USD 165.1M	49K	2025-09
Alterity Therapeutics Limited	AUD 213.97M	144.39K	2023-06
AstraZeneca	USD 1.55B	206K	2025-12
BioCryst Pharmaceuticals	USD 1.9M	3K	2023-09
Bristol-Myers Squibb	USD 2.04B	1.74B	2025-09
Cipla	INR 807.77M	807.43M	2025-09
Clal Biotechnology	ILS 1.61M	0	2022-12
Compugen	USD 93.54M	3.99M	2025-06
CSL	USD 576M	19M	2024-12
Dynavax Technologies	USD 117.23M	117.11M	2025-06
Eli Lilly	USD 946.83M	354.23M	2025-06
Esperion Therapeutics	USD 112K	11K	2023-09
GlaxoSmithKline	GBP 4.08B	49.43M	2025-12
Grifols	EUR 679.73M	0	2025-09
Halozyme Therapeutics	USD 117.52M	98K	2025-09
Ionis Pharmaceuticals	USD 161.14M	160.98M	2025-09
J&J	USD 2.41B	584K	2025-09
Merck	USD 2.49B	15.79M	2025-09
Minerva Neurosciences	USD 1000	0	2024-09
Neurocrine Biosciences	USD 99.7M	700K	2025-09
Novartis	USD 1.94B	23.4M	2025-06
Novavax	USD 1.62M	211K	2024-09
Pfizer	USD 5.69B	1000K	2025-09
Roche Holding	CHF 795.62M	699.54K	2025-12
Takeda	JPY 1.58B	2K	2025-12
Vanda Pharmaceuticals	USD 58K	0	2024-12

Minerva Neurosciences Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.